Form 4 for KVYO Klaviyo, Inc.
Accepted 2024-12-18 00:00:00 ET · period of report 2024-12-16 · accession 0001835830-24-000121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-18 | 2024-12-16 | KVYO | Edmond Landon | CLO | C - Cnv Deriv | — | +102.0K | 338.6K | +43% | — |
| D | 2024-12-18 | 2024-12-16 | KVYO | Edmond Landon | CLO | C - Cnv Deriv | $0.00 | -102.0K | 97.5K | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2024-12-16 | C | A | 101,986 | — | 338,607 | D | — | — | (F1) Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. (F2) Consists of (i) 119,642 shares of Series A Common Stock and (ii) 218,965 unvested restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. |
| 2 | Derivative | Series B Common Stock | 2024-12-16 | C | D | 101,986 | $0.00 | 97,500 | D | — · — to — | 101,986 Series A Common Stock | (F3) Consists of 97,500 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of the Issuer's Series B Common Stock upon vesting and settlement. (F1) Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |